The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients - PubMed (original) (raw)

The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients

Sandra K Thygesen et al. BMC Med Res Methodol. 2011.

Abstract

Background: The Charlson comorbidity index is often used to control for confounding in research based on medical databases. There are few studies of the accuracy of the codes obtained from these databases. We examined the positive predictive value (PPV) of the ICD-10 diagnostic coding in the Danish National Registry of Patients (NRP) for the 19 Charlson conditions.

Methods: Among all hospitalizations in Northern Denmark between 1 January 1998 and 31 December 2007 with a first-listed diagnosis of a Charlson condition in the NRP, we selected 50 hospital contacts for each condition. We reviewed discharge summaries and medical records to verify the NRP diagnoses, and computed the PPV as the proportion of confirmed diagnoses.

Results: A total of 950 records were reviewed. The overall PPV for the 19 Charlson conditions was 98.0% (95% CI; 96.9, 98.8). The PPVs ranged from 82.0% (95% CI; 68.6%, 91.4%) for diabetes with diabetic complications to 100% (one-sided 97.5% CI; 92.9%, 100%) for congestive heart failure, peripheral vascular disease, chronic pulmonary disease, mild and severe liver disease, hemiplegia, renal disease, leukaemia, lymphoma, metastatic tumour, and AIDS.

Conclusion: The PPV of NRP coding of the Charlson conditions was consistently high.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Coding process during an admission to a hospital in Denmark.

Similar articles

Cited by

References

    1. Hall SF. A user's guide to selecting a comorbidity index for clinical research. J Clin Epidemiol. 2006;59:849–855. doi: 10.1016/j.jclinepi.2005.11.013. - DOI - PubMed
    1. Yancik R, Ershler W, Satariano W, Hazzard W, Cohen HJ, Ferrucci L. Report of the national institute on aging task force on comorbidity. J Gerontol A Biol Sci Med Sci. 2007;62:275–280. - PMC - PubMed
    1. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol. 2003;56:221–229. doi: 10.1016/S0895-4356(02)00585-1. - DOI - PubMed
    1. Lash TL, Mor V, Wieland D, Ferrucci L, Satariano W, Silliman RA. Methodology, design, and analytic techniques to address measurement of comorbid disease. J Gerontol A Biol Sci Med Sci. 2007;62:281–285. - PMC - PubMed
    1. Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol. 2000;29:891–898. doi: 10.1093/ije/29.5.891. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources